Evidence map›Paper›PMID 42584522›Full record

ArticleMolecular diversity2026

Deep learning-assisted virtual screening of a large chemical library for selective GSK3β inhibitors.

Tanmaykumar Varma, Pradnya Kamble, Prabha Garg

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tanmaykumar Varma *Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, India.ORCID http://orcid.org/0000-0003-2392-0005
Pradnya Kamble *Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, India.ORCID http://orcid.org/0000-0002-5239-9485
Prabha GargDepartment of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, India. prabhagarg@niper.ac.in.ORCID https://orcid.org/0000-0002-6922-4809

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycogen synthase kinase-3β (GSK3β) is a serine/threonine kinase involved in neurodegenerative, neuropsychiatric, and oncological disorders. The development of selective inhibitors remains challenging due to high kinase conservation, off-target effects, and suboptimal pharmacokinetic properties. A curated dataset of GSK3β molecules was obtained from PubChem, and molecular descriptors were calculated using PaDEL. GSK3BMTPred, a multitask deep neural network (DNN) model, was developed for simultaneous prediction of inhibitor classification and inhibitory potency. The optimized model achieved a training accuracy of 0.9809 for the classification task and a training coefficient of determination (R

Indexed as

Deep learningGSK3Molecular modelingMultitask neural networkSHAP

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.